sovesudil
- Generic Name
- sovesudil
Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Phase 2
Completed
- Conditions
- Ocular HypertensionEye DiseaseGlaucoma
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-05-13
- Last Posted Date
- 2015-01-21
- Lead Sponsor
- Amakem, NV
- Target Recruit Count
- 103
- Registration Number
- NCT02136940
- Locations
- ๐บ๐ธ
Roswell Clinical Site - Site 18, Roswell, Georgia, United States
๐บ๐ธPetaluma Clinical Site - Site 17, Petaluma, California, United States
๐บ๐ธRochester Clinical Site - Site 12, Rochester, New York, United States
A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects
Phase 1
Completed
- Conditions
- GlaucomaOcular HypertensionEye Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-12-06
- Last Posted Date
- 2014-05-02
- Lead Sponsor
- Amakem, NV
- Target Recruit Count
- 21
- Registration Number
- NCT02003547
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Phase 2
Completed
- Conditions
- GlaucomaOcular HypertensionEye Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-09-26
- Last Posted Date
- 2013-07-17
- Lead Sponsor
- Amakem, NV
- Target Recruit Count
- 82
- Registration Number
- NCT01693315
- Locations
- ๐บ๐ธ
Petaluma Clinical Site - Site 05, Petaluma, California, United States
๐บ๐ธArtesia Clinical Site - Site 02, Artesia, California, United States
๐บ๐ธInglewood Clinical Site - Site 03, Inglewood, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath